Skip to main content

Table 1 The occurrence of recurrent vitreous hemorrhage and patient data before and after surgery

From: A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy

 

VA group

TA group

BSS group

P value

Mean age,(yrs)

56.9 ± 11.0

58.1 ± 8.7

58.8 ± 9.9

0.921

Gender,(male/female)

12/6

10/8

19/13

0.784

Cases(n)

18

18

32

 

Cases combinedly received phacomulsification surgery (n)

8

11

15

 

RVH(n)

1

1

4

 

early RVH(n)

0

0

3

 

Late RVH(n)

1

1

1

 

Incidence of RVH(%)

5.56

5.56

12.5

0.602

Incidence of early RVH(%)

0

0

9.4

0.171